Amyloidosis Incidence in High-Risk Cardiac Device Patients

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
AmyloidCardiac AmyloidosisAmyloidosis CardiacSystemic AmyloidosisAL AmyloidosisInfiltrative Cardiomyopathy, AmyloidATTR Amyloidosis Wild Type
Interventions
PROCEDURE

Chest Wall Fat Tissue Collection

As part of routine cardiac device implantation, chest wall fat tissue is collected for histopathological analysis. This tissue, which is typically discarded, will be used to identify amyloid deposits in high-risk cardiac patients. No additional surgical intervention is performed beyond the standard procedure for device implantation.

Trial Locations (1)

66211

RECRUITING

Midwest Heart & Vascular Specialists, Overland Park

All Listed Sponsors
lead

Midwest Heart & Vascular Specialists

OTHER